New technology which gives an unprecedented glimpse inside individual brain cells has been developed by scientists.
Researchers hope the new platform will give them a better grasp of brain diseases.
(ESB Professional/Shutterstock)
Academics at the Salk Institute in California have developed a new genomic technology that can simultaneously analyze DNA, RNA and chromatin, which contains DNA and protein, from a single cell.
The method, which took five years to develop, is a vital step towards large collaborations where several teams can work at the same time to classify thousands of new cell types.
The technology should prove vital for large-scale efforts to develop catalogs of mouse and human brain cell types.
This information can then be used to better understand how the brain grows and develops and the role different cell types play in debilitating diseases such as Alzheimer’s.
Existing single-cell technology works by extracting DNA, RNA or chromatin from a cell’s nucleus and then analyzing its molecular structure for patterns.
However, this destroys the cell in the process, leaving researchers relying on complex algorithms to analyze more than one of these components per cell and compare the results.
For the new method, called snmCAT-seq, scientists used biomarkers to tag DNA, RNA and chromatin without removing them from the cell.
This let them measure all three types of molecular information in the same cell.
This method was then used to identify 63 cell types in the frontal lobe at the front of the brain, a part of the brain that is key to personality development.
It then benchmarked the efficacy of computerized ways of integrating multiple single-cell technologies.
The team found the computer methods are very good at characterizing broadly-defined brain populations but less effective at analyzing less well-defined cell types.
The researchers say cell types need to be defined by a wider range of measurements if they are to be classified more accurately.
The technology could be used to help scientists better understand how genes and cells interact to cause brain diseases.
(Juice Flair/Shutterstock)
The study’s first author Dr. Chongyuan Luo said: ‘’These diseases can broadly affect many cell types, but there are certain cell populations that are particularly vulnerable.
‘’Genetic research has pinpointed the regions of the genome that are relevant for diseases like Alzheimer’s.
‘’We are providing another data dimension and identifying the cell types affected by these genomic reasons.”
The researchers now want to survey other parts of the brain and compare healthy brain cells with ones affected by Alzheimer’s and other brain diseases so those conditions can be better understood.
The findings were published in the journal Cell Genomics.
The research was supported by the US National Institutes of Health, the Howard Hughes Medical Institute and the University of California San Diego.
Stories and infographics by ‘Talker Research’ are available to download & ready to use. Stories and videos by ‘Talker News’ are managed by SWNS. To license content for editorial or commercial use and to see the full scope of SWNS content, please email [email protected] or submit an inquiry via our contact form.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.